ISHARES TR's ticker is IBB and the CUSIP is 464287556. A total of 812 filers reported holding ISHARES TR in Q3 2023. The put-call ratio across all filers is 3.87 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $832,288 | -5.1% | 6,806 | -1.5% | 0.06% | -1.6% |
| Q2 2023 | $876,895 | -2.2% | 6,907 | -0.5% | 0.06% | -3.1% |
| Q1 2023 | $897,007 | +9.0% | 6,945 | +10.8% | 0.06% | +1.6% |
| Q4 2022 | $823,229 | -16.1% | 6,270 | -25.2% | 0.06% | -23.2% |
| Q3 2022 | $981,000 | -5.2% | 8,384 | -4.7% | 0.08% | -1.2% |
| Q2 2022 | $1,035,000 | +10.5% | 8,795 | +22.2% | 0.08% | +31.7% |
| Q1 2022 | $937,000 | -12.5% | 7,195 | +2.6% | 0.06% | -10.0% |
| Q4 2021 | $1,071,000 | -16.5% | 7,015 | -10.5% | 0.07% | -30.7% |
| Q2 2021 | $1,283,000 | +31.2% | 7,839 | +20.7% | 0.10% | +7.4% |
| Q1 2021 | $978,000 | -26.1% | 6,497 | -25.7% | 0.09% | -31.9% |
| Q4 2020 | $1,324,000 | -19.3% | 8,740 | -27.8% | 0.14% | +9.5% |
| Q3 2020 | $1,640,000 | +3.9% | 12,113 | +4.9% | 0.13% | -46.8% |
| Q2 2020 | $1,578,000 | +116.5% | 11,547 | +90.8% | 0.24% | +157.6% |
| Q4 2019 | $729,000 | – | 6,051 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atom Investors LP | 78,501 | $10,139,189 | 5.52% |
| Bronte Capital Management Pty Ltd. | 302,076 | $39,016,136 | 4.53% |
| Michelson Medical Research Foundation, Inc. | 43,395 | $5,604,898 | 4.40% |
| Hackensack Meridian Health, Inc. | 228,000 | $29,448,480 | 4.26% |
| DAFNA Capital Management LLC | 102,500 | $13,238,900 | 3.97% |
| Richmond Brothers, Inc. | 16,724 | $2,159,856 | 3.64% |
| Alpha Family Trust | 34,549 | $4,462,349 | 3.53% |
| HANSEATIC MANAGEMENT SERVICES INC | 11,897 | $1,537 | 3.46% |
| PURSUE WEALTH PARTNERS LLC | 37,789 | $4,880,827 | 3.33% |
| Rye Brook Capital LLC | 40,100 | $5,179 | 3.17% |